Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)

Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study

(2021) Raymond U. Osarogiagbon et al.   Journal of Thoracic Oncology

Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes

(2021) Meredith A. Ray et al.   Journal of Thoracic Oncology

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.

(2020) Jacob Sands et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival After Mediastinal Node Dissection, Systematic Sampling, or Neither for Early Stage NSCLC

(2020) Meredith A. Ray et al.   Journal of Thoracic Oncology

Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings

(2020) Joseph M. Unger et al.   JAMA Network Open

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

(2020) Yi-Long Wu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

(2020) Wen-Zhao Zhong et al.   JOURNAL OF CLINICAL ONCOLOGY

Low nationwide utilization of adjuvant chemotherapy (AC) in elderly patients with localized non-small cell lung cancer (NSCLC).

(2019) Kaushal Parikh et al.   JOURNAL OF CLINICAL ONCOLOGY

Invasive mediastinal staging for resected non–small cell lung cancer in a population-based cohort

(2019) Raymond U. Osarogiagbon et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

(2019) Tony S K Mok et al.   LANCET

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

(2019) Matthew D. Hellmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Disparities in Guideline-Concordant Treatment for Node-positive Non-Small Cell Lung Cancer Following Surgery

(2019) Norma E. Farrow et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR -mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

(2018) Wen-Zhao Zhong et al.   LANCET ONCOLOGY

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

(2018) Jean-Charles Soria et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non–Small Cell Lung Cancer After Resection With Curative Intent

(2018) Matthew P. Smeltzer et al.   JAMA Oncology

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

(2018) Luis Paz-Ares et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabrafenib plus trametinib in patients with previously untreated BRAF V600E -mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

(2017) David Planchard et al.   LANCET ONCOLOGY

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer

(2015) R. Govindan et al.   CLINICAL CANCER RESEARCH

Neighborhood Socioeconomic Disadvantage and 30-Day Rehospitalization

(2014) Amy J.H. Kind et al.   ANNALS OF INTERNAL MEDICINE

Comprehensive molecular profiling of lung adenocarcinoma

(2014) Eric A. Collisson et al.   NATURE

Extension of the modified Poisson regression model to prospective studies with correlated binary data

(2011) GY Zou et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Quality of surgical resection for nonsmall cell lung cancer in a US metropolitan area

(2010) Jeffrey W. Allen et al.   CANCER

Adjuvant Chemotherapy Uptake in Non-small Cell Lung Cancer

(2010) Tallal Younis et al.   Journal of Thoracic Oncology

Underuse of Surgical Resection for Localized, Non–Small Cell Lung Cancer Among Whites and African Americans in South Carolina

(2008) Nestor F. Esnaola et al.   ANNALS OF THORACIC SURGERY

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY